Hyperthyroidism during lithium therapy for depression.

Endocrine Practice : Official Journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists
A A Dwarakanathan

Abstract

To report three cases of hyperthyroidism encountered within a period of 32 months in patients receiving lithium therapy for depression. Three detailed case reports are presented, and the related literature is discussed. Although hypothyroidism during lithium therapy is well recognized and documented, appearance of cases of hyperthyroidism during lithium therapy is considered uncommon. The antithyroid effect of lithium through inhibition of generation of cyclic adenosine monophosphate tends to mask the underlying hyperthyroidism. Nevertheless, during a 32-month period, three cases of hyperthyroidism were encountered in patients who had received lithium treatment (900 to 1,200 mg/day) for 7 months to 17 years. These patients had symptoms of heat intolerance, palpitations, and tremor, and they were subsequently treated successfully with radioactive iodine. Most likely, cases of hyperthyroidism that occur during lithium therapy may be under-diagnosed, underreported, or both.

References

Jun 5, 1976·Lancet·T Cubitt
Jun 26, 1976·Lancet·H H Bafaqeeh, D H Myers
May 1, 1979·The American Journal of Psychiatry·V I ReusR Post
Sep 1, 1979·The Journal of Nervous and Mental Disease·M SchoenbergA N Meisel
Jan 1, 1978·Acta Medica Scandinavica·G Pallisgaard, K Frederiksen
Sep 17, 1977·British Medical Journal·J Merry
Jan 1, 1976·The British Journal of Psychiatry : the Journal of Mental Science·R Rosser
Jun 1, 1976·Australian and New Zealand Journal of Medicine·B E BrownlieR A Donald
Mar 1, 1989·The Journal of Clinical Endocrinology and Metabolism·L E MalletteS Malini
Apr 1, 1986·Postgraduate Medical Journal·C J Thompson, P H Baylis
Dec 1, 1981·The American Journal of Psychiatry·L J ValentaD J Weber

❮ Previous
Next ❯

Citations

Aug 16, 2016·Thyroid : Official Journal of the American Thyroid Association·Douglas S RossMartin A Walter
Mar 8, 2019·The Australian and New Zealand Journal of Psychiatry·Fiona FairbrotherSteve Kisely

❮ Previous
Next ❯

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.

Related Papers

Endocrine Practice : Official Journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists
Andy H Dang, Jerome M Hershman
The American Journal of Medicine
M T McDermottG S Kidd
Endocrine Practice : Official Journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists
C R McHenry, K Lee
Postgraduate Medical Journal
C J Thompson, P H Baylis
© 2022 Meta ULC. All rights reserved